Fred Alger Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Fred Alger Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,365	Closed	-$346K	–	518
2020 Q3	$346K	Buy	+24,365	New	+$372K	﹤0.01%	395
2015 Q4	–	Sell	-874,820	Closed	-$6.88M	–	607
2015 Q3	$6.88M	Sell	874,820 -406,069	-32%	-$3.76M	0.04%	242
2015 Q2	$11.6M	Buy	1,280,889 +371,268	+41%	+$3.74M	0.05%	211
2015 Q1	$11.8M	Buy	+909,621	New	+$11.9M	0.05%	243
2014 Q2	–	Sell	-8,770	Closed	-$87K	–	668
2014 Q1	$87K	Buy	8,770 +210	+2%	+$2.61K	﹤0.01%	472
2013 Q4	$114K	Buy	8,560 +2,275	+36%	+$27.6K	﹤0.01%	446
2013 Q3	$76K	Buy	+6,285	New	+$67.4K	﹤0.01%	460

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fred Alger Management's GNMK Position: Q4 2020 in Review

Fred Alger Management sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 24,365 shares — an estimated $346K sold.

Fred Alger Management first reported a position in GNMK in Q3 2013 and held it in 7 quarters. The position peaked at $11.8M in Q1 2015. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

Fred Alger Management reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
Fred Alger Management sold 24,365 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $346K.
Fred Alger Management first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 7 quarters.
Fred Alger Management's GenMark Diagnostics, Inc position peaked at $11.8M in Q1 2015.
151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Fred Alger Management's 13F filing for Q4 2020, filed 16 Feb 2021.